Skip to main content
The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review.
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.
Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group.
Comment on: Olanzapine for chemotherapy-induced nausea: Lessons learned from child and adolescent psychiatry.
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.